Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by inventorson Nov 19, 2014 1:02pm
466 Views
Post# 23144454

Like a 2nd Offering

Like a 2nd OfferingIMHO..an execution play in the mix...expected standard operating procedure..lol.

First thing that came to my mind...leverage for negotiating...increase share price..and make everyone pay a premium price.

Interesting is that it came at a time milestones start to volume...this has created a perfect bulls/bears battle to chew through potentially 10's of millions of shares...5:1 ratio?

The 'Prospectus' Nov 24 will tell how many $100 millions that the pipeline will generate. Acts like a self marketing tool on guidance and value.

Only one house, canaccord, bought deal, and what is going to trigger the next much higher share price...the deal with upfront...now that would make a great new milestone button.

The 13 M shares are expected to be done by Dec 9...just enough time for the Nov 24 prospectus, and inking of a deal. it is not uncommon to accelerate the timeline however does the buyer already have a new buyer in the mix...and announce either an over subscription or closes early.


Perhaps a stalemate on upfront and next news could drive the sp big time within reason of coarse, however, just in time for new TSX SmallCap additions...healthcare...and growth funds,


One more point...this is part of addition working cap...and 25% could be used as money flow to keep the sp in relative strength. 
Bullboard Posts